相关实验视频

Updated: Jan 14, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

对降低新型非阿片类止痛药肝毒性的结构基础的计算洞察力

Claire Coderch¹, Hernan A Bazán², Nicolas G Bazan^3,4

¹Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668, Madrid, Spain.

|October 21, 2025

概括

乙氨基的毒性源于NAPQI,导致肝脏和脏受损. 计算分析显示,新型止痛药,如化合物6,可降低毒性并改善药物特性.

科学领域:

药用化学医学化学
计算毒理学计算毒理学
药理学药理学是指药理学的学科.

背景情况:

乙氨基 (ApAP) 的毒性是一个重大问题,主要是由于反应性中间体N-乙-p-基胺 (NAPQI),这可能会导致严重的肝脏和脏损伤.
作为一种非类固醇抗炎药物,ApAP的广泛使用需要开发更安全的替代品.
现有的新型止痛药候选药物显示毒性降低,但潜在的分子机制尚不清楚.

研究的目的:

调查负责新型非阿片类止痛药候选者的毒性降低的分子和原子层次机制.
探索这些新化学实体 (NCE) 的动态行为,物理化学性质和联体受体相互作用.
为设计更安全的止痛药提供合理的基础,具有更好的代谢和药物动力学特征.

主要方法:

运用计算分析来研究NCE的动态行为.
通过计算评估了NCE的物理化学特性.
使用计算方法研究了连接物-受体相互作用.

主要成果:

计算发现为新型止痛药候选者的不同毒性概况提供了合理的解释.
该研究提供了对这些NCEs的代谢途径的见解.
化合物6被确定为ApAP的有希望的替代品,具有潜在的降低肝毒性.

结论:

计算调查阐明了新型止痛药候选物的降低毒性背后的机制.
化合物6显示出作为一种更安全的止痛药的潜力,目前正在开发中.
这些发现有助于设计未来的无肝毒性止痛药,增强药物代谢和药理动力学.

关键词:

N-乙-p-本佐基诺因 imine 的使用.乙氨基毒性乙氨基毒性停靠的对接方式药物代谢和药物动力学分子动力学分子动力学新的化学实体是新的化学实体.新型非阿片类止痛药是一种非阿片类止痛药.

更多相关视频

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Phase I Reactions: Reductive Reactions

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...